Y0000788

Indinavir

Name: Indinavir
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

別名:

Indinavir monohydrate

ログインで組織・契約価格をご覧ください。

サイズを選択してください

この商品について

実験式（ヒル表記法）:

C₃₆H₄₇N₅O₄ · H₂O

CAS番号:

180683-37-8

分子量:

631.80

UNSPSC Code:

41116107

NACRES:

NA.24

主要文書

すべての文書を表示

テクニカルサービス

お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。

お手伝いします

テクニカルサービス

お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。

お手伝いします

SMILES string

N4([C@@H](CN(CC4)Cc5cnccc5)C(=O)NC(C)(C)C)C[C@@H](O)C[C@@H](Cc3ccccc3)C(=O)N[C@@H]1[C@@H](Cc2c1cccc2)O.O

InChI

1S/C36H47N5O4.H2O/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43;/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45);1H2/t28-,29+,31+,32-,33+;/m1./s1

InChI key

XTYSXGHMTNTKFH-BDEHJDMKSA-N

grade

pharmaceutical primary standard

API family

indinavir

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

類似した製品をお探しですか？訪問製品比較ガイド

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Indinavir EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

pictograms

GHS07

signalword

Warning

hcodes

H315

pcodes

P264 - P280 - P302 + P352 - P332 + P313 - P362 + P364

Hazard Classifications

Skin Irrit. 2

保管分類

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Y0000788: + Y0000788-1EA:

jan

最新バージョンのいずれかを選択してください：

試験成績書（COA）

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせくださいカスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Production of pure indinavir free base nanoparticles by a supercritical anti-solvent (SAS) method.

Julieta C Imperiale et al.

Drug development and industrial pharmacy, 40(12), 1607-1615 (2013-09-21)

This work investigated the production of pure indinavir free base nanoparticles by a supercritical anti-solvent method to improve the drug dissolution in intestine-like medium. To increase the dissolution of the drug by means of a supercritical fluid processing method. Acetone

Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease.

Dario Akaberi et al.

Journal of biomolecular structure & dynamics, 38(18), 5526-5536 (2019-12-28)

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus and infection by ZIKV Asian lineage is known to cause fetal brain anomalies and Guillain-Barrés syndrome. The WHO declared ZIKV a global public health emergency in 2016. However, currently neither vaccines nor

Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea.

Oh-Kyung Kwon et al.

Virology journal, 12, 53-53 (2015-04-17)

In South Korea, about 20 types of antiretroviral drugs are used in the treatment of patients with human immunodeficiency virus/acquired immune deficiency syndrome. Since 2010, raltegravir, etravirine, and darunavir have been spotlighted as new drugs for highly active antiretroviral therapy

cAMP-dependent insulin modulation of synaptic inhibition in neurons of the dorsal motor nucleus of the vagus is altered in diabetic mice.

Camille B Blake et al.

American journal of physiology. Regulatory, integrative and comparative physiology, 307(6), R711-R720 (2014-07-06)

Pathologies in which insulin is dysregulated, including diabetes, can disrupt central vagal circuitry, leading to gastrointestinal and other autonomic dysfunction. Insulin affects whole body metabolism through central mechanisms and is transported into the brain stem dorsal motor nucleus of the

Blood-brain barrier pharmacoproteomics-based reconstruction of the in vivo brain distribution of P-glycoprotein substrates in cynomolgus monkeys.

Yasuo Uchida et al.

The Journal of pharmacology and experimental therapeutics, 350(3), 578-588 (2014-06-21)

The aim of this study was to investigate whether in vivo drug distribution in brain in monkeys can be reconstructed by integrating four factors: protein expression levels of P-glycoprotein (P-gp)/multidrug resistance protein 1 at the blood-brain barrier (BBB), in vitro

Indinavir

European Pharmacopoeia (EP) Reference Standard

サイズを選択してください

この商品について

主要文書

特性

SMILES string

InChI

InChI key

grade

API family

manufacturer/tradename

application(s)

format

storage temp.

関連するカテゴリー

詳細

General description

Application

Packaging

Other Notes

安全性情報

pictograms

signalword

hcodes

pcodes

Hazard Classifications

保管分類

wgk

flash_point_f

flash_point_c

適用法令

Y0000788: + Y0000788-1EA:

資料

試験成績書（COA）

以前この製品を購入いただいたことがある場合

参考文献

テクニカルサービス